Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1769) 1769
carmustine - administration & dosage (1606) 1606
male (1264) 1264
female (1262) 1262
science & technology (1138) 1138
life sciences & biomedicine (1121) 1121
middle aged (1032) 1032
adult (996) 996
antineoplastic combined chemotherapy protocols - therapeutic use (925) 925
biological and medical sciences (855) 855
medical sciences (843) 843
oncology (696) 696
aged (626) 626
pharmacology. drug treatments (577) 577
chemotherapy (557) 557
combined modality therapy (545) 545
antineoplastic agents (544) 544
animals (526) 526
cyclophosphamide - administration & dosage (512) 512
carmustine - therapeutic use (508) 508
brain neoplasms - drug therapy (455) 455
melphalan - administration & dosage (418) 418
etoposide - administration & dosage (401) 401
carmustine - adverse effects (400) 400
antineoplastic combined chemotherapy protocols - adverse effects (364) 364
cytarabine - administration & dosage (349) 349
hematology (342) 342
antineoplastic combined chemotherapy protocols - administration & dosage (326) 326
treatment outcome (318) 318
adolescent (313) 313
vincristine - administration & dosage (311) 311
transplantation, autologous (295) 295
abridged index medicus (277) 277
mice (273) 273
cisplatin - administration & dosage (270) 270
glioma - drug therapy (257) 257
carmustine (256) 256
doxorubicin - administration & dosage (231) 231
prognosis (226) 226
survival analysis (224) 224
prednisone - administration & dosage (222) 222
antineoplastic agents, alkylating - administration & dosage (220) 220
transplantation (219) 219
antineoplastic agents - administration & dosage (217) 217
survival rate (210) 210
bone marrow transplantation (207) 207
time factors (205) 205
hematopoietic stem cell transplantation (200) 200
drug therapy, combination (196) 196
glioblastoma - drug therapy (191) 191
rats (191) 191
carmustine - pharmacology (189) 189
disease-free survival (188) 188
neurosciences & neurology (188) 188
cancer (175) 175
clinical neurology (174) 174
drug administration schedule (165) 165
follow-up studies (164) 164
dose-response relationship, drug (162) 162
remission induction (160) 160
retrospective studies (160) 160
dacarbazine - administration & dosage (152) 152
antineoplastic agents - therapeutic use (145) 145
immunology (141) 141
bcnu (140) 140
hodgkin disease - drug therapy (133) 133
multiple myeloma - drug therapy (131) 131
medicine & public health (128) 128
neurology (128) 128
hodgkin disease - therapy (126) 126
combined treatments (120) 120
brain neoplasms - radiotherapy (119) 119
child (117) 117
prospective studies (116) 116
antineoplastic agents, alkylating - therapeutic use (115) 115
melanoma - drug therapy (115) 115
pharmacology & pharmacy (115) 115
clinical trials as topic (114) 114
lymphoma, non-hodgkin - drug therapy (111) 111
care and treatment (110) 110
lymphoma, non-hodgkin - therapy (110) 110
recurrence (109) 109
tumors (109) 109
brain neoplasms - surgery (108) 108
stem cells (108) 108
brain neoplasms - pathology (107) 107
methotrexate - administration & dosage (107) 107
dexamethasone - administration & dosage (105) 105
hematologic and hematopoietic diseases (101) 101
surgery (101) 101
carmustine - toxicity (100) 100
biophysics (99) 99
brain neoplasms - therapy (99) 99
neoplasm transplantation (99) 99
podophyllotoxin - administration & dosage (98) 98
fluorouracil - administration & dosage (97) 97
brain neoplasms - mortality (95) 95
drug evaluation (94) 94
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (93) 93
cyclophosphamide - therapeutic use (91) 91
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2130) 2130
German (24) 24
Japanese (22) 22
Russian (21) 21
Spanish (20) 20
French (17) 17
Chinese (10) 10
Polish (9) 9
Italian (6) 6
Czech (2) 2
Danish (1) 1
Hebrew (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study
by Chiappella, Annalisa and Martelli, Maurizio and Angelucci, Emanuele and Brusamolino, Ercole and Evangelista, Andrea and Carella, Angelo Michele and Stelitano, Caterina and Rossi, Giuseppe and Balzarotti, Monica and Merli, Francesco and Gaidano, Gianluca and Pavone, Vincenzo and Rigacci, Luigi and Zaja, Francesco and D'Arco, Alfonso and Cascavilla, Nicola and Russo, Eleonora and Castellino, Alessia and Gotti, Manuel and Congiu, Angela Giovanna and Cabras, Maria Giuseppina and Tucci, Alessandra and Agostinelli, Claudio and Ciccone, Giovannino and Pileri, Stefano A and Vitolo, Umberto
The lancet oncology, ISSN 1470-2045, 08/2017, Volume 18, Issue 8, pp. 1076 - 1088
Life Sciences & Biomedicine | Oncology | Science & Technology | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Mitoxantrone - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Induction Chemotherapy | Male | Transplantation, Autologous | Consolidation Chemotherapy | Cyclophosphamide - adverse effects | Lymphoma, Large B-Cell, Diffuse - therapy | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Hematologic Diseases - chemically induced | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Prednisone - adverse effects | Risk Factors | Etoposide - administration & dosage | Survival Rate | Cytarabine - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Intention to Treat Analysis | Vincristine - adverse effects | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Carmustine - administration & dosage | Stem Cell Transplantation - adverse effects | Stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma – results of the UK HD3 relapse treatment strategy
by Shankar, Ananth and Hayward, Janis and Kirkwood, Amy and McCarthy, Keith and Hewitt, Martin and Morland, Bruce and Daw, Stephen
British journal of haematology, ISSN 0007-1048, 05/2014, Volume 165, Issue 4, pp. 534 - 544
refractory disease | relapse | children | survival | Hodgkin lymphoma | Relapse | Children | Refractory disease | Survival | Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Procarbazine - administration & dosage | Prednisolone - adverse effects | Recurrence | Cyclophosphamide - administration & dosage | Prednisolone - administration & dosage | Follow-Up Studies | Humans | Vinblastine - administration & dosage | Cyclophosphamide - adverse effects | Hodgkin Disease - surgery | Hodgkin Disease - mortality | Vincristine - administration & dosage | Child | Dacarbazine - administration & dosage | Dexamethasone - administration & dosage | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Combined Modality Therapy | Bleomycin - administration & dosage | Remission Induction | Cytarabine - administration & dosage | Ifosfamide - administration & dosage | Adolescent | Vincristine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Cisplatin - administration & dosage | Hodgkin Disease - radiotherapy | Multicenter Studies as Topic | Hodgkin Disease - drug therapy | Retrospective Studies | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Chlorambucil - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Ifosfamide - adverse effects | Kaplan-Meier Estimate | Treatment Outcome | Clinical Trials as Topic | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Carmustine - administration & dosage | Patient outcomes | Diseases | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text MYC + diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation
by Cuccuini, Wendy and Briere, Josette and Mounier, Nicolas and Voelker, Hans-Ullrich and Rosenwald, Andreas and Sundstrom, Christer and Cogliatti, Sergio and Hirchaud, Edouard and Ysebaert, Loic and Bron, Dominique and Soulier, Jean and Gaulard, Philippe and Houlgatte, Remi and Gisselbrecht, Christian and Thieblemont, Catherine
Blood, ISSN 0006-4971, 05/2012, Volume 119, Issue 20, pp. 4619 - 4624
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Podophyllotoxin - adverse effects | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Dexamethasone - adverse effects | Male | Transplantation, Autologous | Cytarabine - adverse effects | Cisplatin - administration & dosage | Young Adult | Lymphoma, Large B-Cell, Diffuse - therapy | Melphalan - adverse effects | Immunotherapy | Treatment Failure | Podophyllotoxin - administration & dosage | Adult | Female | Chemotherapy, Adjuvant | Carmustine - adverse effects | Genes, myc - physiology | Dexamethasone - administration & dosage | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Ifosfamide - adverse effects | Rituximab | Etoposide - administration & dosage | Combined Modality Therapy | Cytarabine - administration & dosage | Lymphoma, Large B-Cell, Diffuse - mortality | Melphalan - administration & dosage | Ifosfamide - administration & dosage | Cisplatin - adverse effects | Aged | Hematopoietic Stem Cell Transplantation - methods | Antibodies, Monoclonal, Murine-Derived - adverse effects | Lymphoma, Large B-Cell, Diffuse - genetics | Carmustine - administration & dosage | Index Medicus | Abridged Index Medicus | Life Sciences | Biochemistry, Molecular Biology | Lymphoma, Large B-Cell, Diffuse | Podophyllotoxin | methods | Genes, myc | Cytarabine | genetics | administration & dosage | Melphalan | Antibodies, Monoclonal, Murine-Derived | Dexamethasone | drug therapy | Ifosfamide | Carmustine | therapy | Antineoplastic Combined Chemotherapy Protocols | Etoposide | physiology | Hematopoietic Stem Cell Transplantation | Cisplatin | adverse effects | mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin’s lymphoma
by García‐Sanz, R and González‐López, T.J and Vázquez, L and Hermida, G and Graciani, I.F and San Miguel, J.F
European journal of haematology, ISSN 0902-4441, 03/2010, Volume 84, Issue 3, pp. 266 - 270
dexamethasone | refractory disease | cyclophosphamide | thalidomide | transplantation | Hodgkin's lymphoma | Cyclophosphamide | Transplantation | Dexamethasone | Refractory disease | Thalidomide | Life Sciences & Biomedicine | Hematology | Science & Technology | Procarbazine - administration & dosage | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prednisolone - administration & dosage | Humans | Salvage Therapy | Drug Resistance, Neoplasm | Male | Transplantation, Autologous | Vinblastine - administration & dosage | Hodgkin Disease - surgery | Cisplatin - administration & dosage | Hodgkin Disease - radiotherapy | Organoplatinum Compounds - administration & dosage | Hodgkin Disease - drug therapy | Vincristine - administration & dosage | Adult | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Prednisone - administration & dosage | Antibodies, Monoclonal, Murine-Derived | Dexamethasone - administration & dosage | Deoxycytidine - administration & dosage | Rituximab | Etoposide - administration & dosage | Combined Modality Therapy | Vidarabine - analogs & derivatives | Bleomycin - administration & dosage | Thalidomide - administration & dosage | Remission Induction | Cytarabine - administration & dosage | Melphalan - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Topotecan - administration & dosage | Mechlorethamine - administration & dosage | Vidarabine - administration & dosage | Peripheral Blood Stem Cell Transplantation | Deoxycytidine - analogs & derivatives | Carmustine - administration & dosage | Antimitotic agents | Stem cells | Antineoplastic agents | Hodgkin's disease | Steroids | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Convection enhanced delivery of anti-angiogenic and cytotoxic agents in combination therapy against brain tumour
by Zhan, Wenbo
European journal of pharmaceutical sciences, ISSN 0928-0987, 01/2020, Volume 141, pp. 105094 - 105094
Drug transport | Brain tumour | Mathematical modelling | Anti-angiogenesis | Convection enhanced delivery | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Cisplatin - pharmacokinetics | Humans | Methotrexate - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Brain Neoplasms - pathology | Cytotoxins - administration & dosage | Brain Neoplasms - blood supply | Paclitaxel - pharmacokinetics | Brain Neoplasms - metabolism | Convection | Cisplatin - administration & dosage | Angiogenesis Inhibitors - administration & dosage | Fluorouracil - administration & dosage | Paclitaxel - administration & dosage | Doxorubicin - administration & dosage | Carmustine - pharmacokinetics | Bevacizumab - administration & dosage | Bevacizumab - pharmacokinetics | Microvessels - drug effects | Angiogenesis Inhibitors - pharmacokinetics | Brain Neoplasms - drug therapy | Doxorubicin - pharmacokinetics | Models, Biological | Methotrexate - administration & dosage | Fluorouracil - pharmacokinetics | Cytotoxins - pharmacokinetics | Carmustine - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation
by Paiva, Bruno and Vidriales, Maria-Belén and Cerveró, Jorge and Mateo, Gema and Pérez, Jose J and Montalbán, Maria A and Sureda, Anna and Montejano, Laura and Gutiérrez, Norma C and De Coca, Alfonso García and De Las Heras, Natalia and Mateos, Maria V and López-Berges, Maria C and García-Boyero, Raimundo and Galende, Josefina and Hernández, Jose and Palomera, Luis and Carrera, Dolores and Martínez, Rafael and De La Rubia, Javier and Martín, Alejandro and Bladé, Joan and Lahuerta, Juan J and Orfao, Alberto and San Miguel, Jesús F and GEM Grp Espanol MM PETHEMA and GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Groups
Blood, ISSN 0006-4971, 11/2008, Volume 112, Issue 10, pp. 4017 - 4023
Life Sciences & Biomedicine | Hematology | Science & Technology | Predictive Value of Tests | Flow Cytometry - methods | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Multiple Myeloma - mortality | Humans | Middle Aged | Male | Transplantation, Autologous | Cisplatin - administration & dosage | Neoplasm, Residual | Multiple Myeloma - therapy | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Multiple Myeloma - blood | Dexamethasone - administration & dosage | Multiple Myeloma - diagnosis | Survival Rate | Bleomycin - administration & dosage | Disease-Free Survival | Stem Cell Transplantation - methods | Aged | Mitomycin - administration & dosage | Carmustine - administration & dosage | Index Medicus | Abridged Index Medicus | Clinical Trials and Observations
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Nordic MCL2 trial update: six‐year follow‐up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem‐cell support: still very long survival but late relapses do occur
by Geisler, Christian H and Kolstad, Arne and Laurell, Anna and Jerkeman, Mats and Räty, Riikka and Andersen, Niels S and Pedersen, Lone B and Eriksson, Mikael and Nordström, Marie and Kimby, Eva and Bentzen, Hans and Kuittinen, Outi and Lauritzsen, Grete F and Nilsson‐Ehle, Herman and Ralfkiær, Elisabeth and Ehinger, Mats and Sundström, Christer and Delabie, Jan and Karjalainen‐Lindsberg, Marja‐Liisa and Brown, Peter and Elonen, Erkki and Nordic Lymphoma Group and for the Nordic Lymphoma Group
British journal of haematology, ISSN 0007-1048, 08/2012, Volume 158, Issue 3, pp. 355 - 362
autologous stem cell transplant | mantle cell lymphoma | high‐dose AraC | pre‐emptive therapy | rituximab | Pre-emptive therapy | Autologous stem cell transplant | Rituximab | High-dose AraC | Mantle cell lymphoma | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Recurrence | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Lymphoma, Mantle-Cell - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Immunotherapy | Podophyllotoxin - administration & dosage | Female | Lymphoma, Mantle-Cell - drug therapy | Etoposide - administration & dosage | Survival Rate | Cytarabine - administration & dosage | Disease-Free Survival | Lymphoma, Mantle-Cell - therapy | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Mantle-Cell - immunology | Aged | Hematopoietic Stem Cell Transplantation - methods | Carmustine - administration & dosage | Transplantation | Lymphomas | Stem cells | Index Medicus | Clinical trials | Autografts | Cell survival | Survival | stem cell transplantation | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
by Weihrauch, Martin R and Re, Daniel and Scheidhauer, Klemens and Ansén, Sascha and Dietlein, Markus and Bischoff, Stefanie and Bohlen, Heribert and Wolf, Jürgen and Schicha, Harald and Diehl, Volker and Tesch, Hans
Blood, ISSN 0006-4971, 11/2001, Volume 98, Issue 10, pp. 2930 - 2934
Biological and medical sciences | Radionuclide investigations | Investigative techniques, diagnostic techniques (general aspects) | Medical sciences | Blood cells | Hodgkin Disease - diagnostic imaging | Procarbazine - administration & dosage | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Follow-Up Studies | Hodgkin Disease - pathology | Humans | Salvage Therapy | Transplantation, Autologous | Life Tables | Vinblastine - administration & dosage | False Positive Reactions | Mediastinal Neoplasms - therapy | Hodgkin Disease - mortality | Vincristine - administration & dosage | Radiopharmaceuticals | Radiotherapy, Adjuvant | Doxorubicin - administration & dosage | Dacarbazine - administration & dosage | Diagnosis, Differential | Prednisone - administration & dosage | Dexamethasone - administration & dosage | False Negative Reactions | Hematopoietic Stem Cell Transplantation | Etoposide - administration & dosage | Combined Modality Therapy | Neoplasm Recurrence, Local - diagnosis | Bleomycin - administration & dosage | Mediastinal Neoplasms - diagnostic imaging | Remission Induction | Cytarabine - administration & dosage | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - pathology | Hodgkin Disease - therapy | Fibrosis | Fluorodeoxyglucose F18 | Tomography, Emission-Computed | Carmustine - administration & dosage | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
by Mercadal, S and Briones, J and Xicoy, B and Pedro, C and Escoda, L and Estany, C and Camós, M and Colomo, L and Espinosa, Í and Martínez, S and Ribera, J.M and Martino, R and Gutiérrez-García, G and Montserrat, E and López-Guillermo, A and Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB)
Annals of oncology, ISSN 0923-7534, 5/2008, Volume 19, Issue 5, pp. 958 - 963
Autologous stem-cell transplantation | Peripheral T-cell lymphoma | Prognosis | Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Cytarabine - adverse effects | Cyclophosphamide - adverse effects | Cisplatin - administration & dosage | Vincristine - administration & dosage | Adult | Female | Lymphoma, T-Cell, Peripheral - classification | Doxorubicin - administration & dosage | Lymphoma, T-Cell, Peripheral - drug therapy | Prednisone - administration & dosage | Etoposide - adverse effects | Prednisone - adverse effects | Etoposide - administration & dosage | Treatment Outcome | Combined Modality Therapy | Remission Induction | Cytarabine - administration & dosage | Neoplasms, Second Primary - epidemiology | Disease-Free Survival | Melphalan - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Vincristine - adverse effects | Lymphoma, T-Cell, Peripheral - surgery | Aged | Transplantation Conditioning | Peripheral Blood Stem Cell Transplantation | Doxorubicin - adverse effects | Carmustine - administration & dosage | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Intensification treatment based on early FDG‐PET in patients with high‐risk diffuse large B‐cell lymphoma: a phase II GELTAMO trial
by Pardal, Emilia and Coronado, Mónica and Martín, Alejandro and Grande, Carlos and Marín‐Niebla, Ana and Panizo, Carlos and Bello, José Luis and Conde, Eulogio and Hernández, Miguel T and Arranz, Reyes and Bargay, Joan and